Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

RAC Device Practice Question Set 6, Quizzes of Law

RAC Device Practice Question Set 3- US

Typology: Quizzes

2024/2025

Uploaded on 04/07/2025

sandeep-srivastava-5
sandeep-srivastava-5 🇮🇳

13 documents

1 / 4

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Question
Answer
Explanation
A medical device company plans to modify
an FDA-cleared infusion pump to include
wireless connectivity for remote
monitoring. The intended use remains t he
same, but the modification allows
healthcare providers to adjust infusion
settings remotely.
What is the most appropriate regulatory
action?
A) No new 510(k) is required, as the
intended use remains unchanged
B) Submit a Special 510(k) because the
modification is a minor design change
C) Submit a new Traditional 510(k)
because the wireless feature introduces new
risks
D) Submit a PMA because the change
significantly alters the device
C) Submit a new Traditional 510(k)
because the wireless feature introduces new
risks
A manufacturer of an FDA-cleared Class II
laparoscopic surgical tool wants to make a
cosmetic change by switching from blue to
black casing for better visibility in low-light
surgical environments. The device's
materials, design, and intended use remain
unchanged.
What is the most appropriate regulatory
action?
A) Submit a new Traditional 510(k)
B) Submit a Special 510(k)
C) Submit a PMA supplement
D) No new 510(k) is required
D) No new 510(k) is required
The correct answer is D. A 510(k) is not required
for purely cosmetic changes that do not affect the
safety or effectiveness of the device. Since the
materials, design, and intended use remain
unchanged, the manufacturer can document t he
change internally as part of design controls and
change management records under 21 CFR
820.30(i) (Design Changes).
pf3
pf4

Partial preview of the text

Download RAC Device Practice Question Set 6 and more Quizzes Law in PDF only on Docsity!

Question Answer Explanation A medical device company plans to modify an FDA-cleared infusion pump to include wireless connectivity for remote monitoring. The intended use remains the same, but the modification allows healthcare providers to adjust infusion settings remotely. What is the most appropriate regulatory action? A) No new 510(k) is required, as the intended use remains unchanged B) Submit a Special 510(k) because the modification is a minor design change C) Submit a new Traditional 510(k) because the wireless feature introduces new risks D) Submit a PMA because the change significantly alters the device C) Submit a new Traditional 510(k) because the wireless feature introduces new risks A manufacturer of an FDA-cleared Class II laparoscopic surgical tool wants to make a cosmetic change by switching from blue to black casing for better visibility in low-light surgical environments. The device's materials, design, and intended use remain unchanged. What is the most appropriate regulatory action? A) Submit a new Traditional 510(k) B) Submit a Special 510(k) C) Submit a PMA supplement D) No new 510(k) is required D) No new 510(k) is required The correct answer is D. A 510(k) is not required for purely cosmetic changes that do not affect the safety or effectiveness of the device. Since the materials, design, and intended use remain unchanged, the manufacturer can document the change internally as part of design controls and change management records under 21 CFR 820.30(i) (Design Changes).

A medical device startup is developing a Class II glucose monitoring system that connects to a smartphone app via Bluetooth. The company plans to submit a 510(k) using a predicate device that only includes a wired data connection (USB). What is the most likely FDA response? A) The FDA will approve the 510(k) since both devices measure glucose levels B) The FDA will require cybersecurity testing and validation for the wireless functionality C) The FDA will require the company to submit a De Novo request D) The company does not need to submit a new 510(k) since only the data connection method changed B) The FDA will require cybersecurity testing and validation for the wireless functionality A manufacturer submits a 510(k) for a new orthopedic bone screw. The FDA responds with an Additional Information (AI) request, asking for mechanical strength testing data to demonstrate equivalence to the predicate. What happens to the 90-day review clock while the company gathers and submits the requested data? A) The clock pauses until the company submits the requested information within 180 days. B) The clock continues running, and failure to submit within the timeframe may lead to an NSE (Not Substantially Equivalent) decision C) The company gets an automatic extension beyond 90 days to collect data D) The clock resets to 90 days once the additional information is submitted A) The clock pauses until the company submits the requested information within 180 days. RAC Book page 189. Additional Information (AI) Request and Clock Pause: When the FDA issues an AI request, it effectively pauses the 90-day review clock. The clock remains paused until the manufacturer submits a complete response to the AI request. This allows the manufacturer the necessary time to gather and submit the requested data without being penalized by the original 90-day timeframe.

Company Z's device has been found Not Substantially Equivalent (NSE) after 510(k) review. What is their best immediate course of action? a) Immediately resubmit the same 510(k) with minor changes b) Appeal the decision within 30 days c) Start selling the device in international markets d) Evaluate the NSE letter and consider a De Novo submission d) Evaluate the NSE letter and consider a De Novo submission Explanation: The correct answer is D) Evaluate the NSE letter and consider a De Novo submission. After receiving an NSE decision, the company should carefully review the FDA's reasoning. If the device is low to moderate risk, a De Novo submission might be appropriate to establish a new classification for the device. A medical device manufacturer is preparing a Special 510(k) for a modification to their cleared device. Which of the following changes would NOT be appropriate for a Special 510(k)? a) Changing the sterilization method b) Modifying the device's dimensions within pre-established limits c) Adding a new indication for use d) Updating the device's software with new features within its cleared intended use c) Adding a new indication for use Special 510(k)s are intended for modifications that do not affect the device's intended use or fundamental scientific technology. Adding a new indication for use would likely require a Traditional 510(k). A company is considering using the Safety and Performance Based Pathway for their 510(k) submission. Which of the following is a requirement for this pathway? a) The device must be a Class III device b) The device must have a corresponding FDA-recognized consensus standard c) The company must have previously cleared devices in the same product code d) Clinical data is always required, regardless of the device type b) The device must have a corresponding FDA-recognized consensus standard RAC Book page 149. Safety and Performance Based Pathway Company C's 510(k) submission has been placed on Refuse to Accept (RTA) hold. What is the timeframe for them to respond with the requested information? a) 30 calendar days b) 45 calendar days c) 60 calendar days d) 180 calendar days d) 180 calendar days RAC Book page 149.